Hypoglycemic effect of hazelnut and its effect on some sex hormones in alloxan induced diabetic in female rats

Pakistan Journal of Nutrition

Volumn 12, Issue 3, 2013, Pages 229-238

  Abeer, E El Khamisy ^a   Amr, A Rezq ^b  

^a PORT SAID UNIVERSITY   (Egypt)

^b HELWAN UNIVERSITY   (Egypt)

Author keywords

Diabetes mellitus; Follicle stimulating hormone; Hazelnut; Kidney functions; Liver functions; Luteinizing hormone; Thyroid

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CHOLESTEROL; CREATININE; FOLLITROPIN; GLUCOSE; INSULIN; LIPID; LUTEINIZING HORMONE; NITROGEN; SEX HORMONE; THYROTROPIN; TRIACYLGLYCEROL; UREA; URIC ACID;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALLOXAN DIABETES MELLITUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CELL HYPERPLASIA; CELL NUCLEUS; CHOLESTEROL BLOOD LEVEL; CONNECTIVE TISSUE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DIET SUPPLEMENTATION; FEMALE; FOLLITROPIN BLOOD LEVEL; FOOD INTAKE; GLUCOSE BLOOD LEVEL; HAZELNUT; HISTOLOGY; HYPERTROPHY; INSULIN BLOOD LEVEL; LIPID BLOOD LEVEL; LUTEINIZING HORMONE BLOOD LEVEL; NONHUMAN; OOCYTE; OVARY; PANCREAS ISLET BETA CELL; RANDOMIZATION; RAT; THYROTROPIN BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; UREA NITROGEN BLOOD LEVEL; URIC ACID BLOOD LEVEL; VASODILATATION; WEIGHT GAIN;

ANIMALIA; CORYLUS; RATTUS;

EID: 84879252837     PISSN: 16805194     EISSN: None     Source Type: Journal    
DOI: 10.3923/pjn.2013.229.238     Document Type: Article

References (61)

1. Alasalvar, C., F. Shahidi and K.R. Cadwallader, 2003. Comparison of natural and roasted Turkish Tombul hazelnut (Corylus avellana L.) volatiles and flavor by DHA/GC/MS and descriptive sensory analysis. J. Agric. Food Chem., 51: 5067-5072.
2. Alasalvar, C., J.S. Amaral and F. Shahidi, 2006. Functional lipid characteristics of Turkish Tombul hazelnut (Corylus avellana L.). J. Agric. Food Chem., 54: 10177-10183.
3. American Diabetes Association (ADA), 2007. Diagnosis and classification of diabetes mellitus. Diabetes Care, 30: 42-47.
4. Ana Angelica, H., F. Ethel, L.B. Ary and M.G. Cristiano, 2009. Effect of naringerin on biochemical parameters in the streptozotocin-induced diabetic rats. Brazilian Arch. Biol. Technol., 52: 51-59.
5. Anderson, J.W., P. Baird, R. Davis, S. Ferreri, M. Knudtson, A. Koraym, V. Waters and C.L. Williams, 2009. Health Benefit Dietary Fiber. Nutr. Rev., 67: 188-205.
6. Ballester, J., M.C. Munoz, J. Dominguez, M.J. Palomo, M., Rivera, T. Rigau, J.J. Guinovart and J.E. Rodrfguez- Gil, 2007. Tungstate administration improves the sexual and reproductive function in female rats with streptozotocin-induced diabetes. Hum Reprod., 22: 2128-2135.
7. Bansal, V., J. Kalita and U.K. Misra, 2006. Diabetic neuropathy. Postgrad Med. J., 82: 95-100.
8. Bolkent, S., R. Yanardag, B.O. Karabulut and S.O. Ozsoy, 2004. The morphological and biochemical effects of glibornuride on rat in experimental diabetes. Human Exp. Toxicol., 23: 257-264.
9. Brown, L., B. Rosner, W.W. Willett and F.M. Sacks, 1999. Cholesterol-lowering effects of dietary fiber: A metaanalysis. Am. J. Clin. Nutr., 69: 30-42.
10. Brown, A.A. and F.B. Hu, 2001. Dietary modulation of endothelial function. Implications for cardiovascular disease. Am. J. Clin. Nutr., 73: 673-686.
11. Buko, V., O. Lukivskayam, V. Nikitin, Y. Tarasov, L. Zavodnik, A. Borodinsky and B. Gorenshtein, 1996. Hepatic and pancreatic effects of olyenoyl- phosphatidylcholine in rats with alloxan induced diabetes. Cell Biochem. Funct., 14: 131-137.
12. Carleton, H., 1979. Histological techniques. 4th Edn., London, Oxford University Press, New York, USA, Toronto, pp: 267.
13. Choi, C.W., S.C. Kim, S.S. Hwang, B.K. Choi, H.J. Ahn, M.Y. Lee, S.H. Park and S.K. Kim, 2002. Antioxidant activity and free radical scavenging capacity between Korean medicinal plants and flavonoids by assay-guided comparison. Plant Sci., 163: 1161-1168.
14. Cooke, J.P. and P.S. Tsao, 1997. Arginine: A new therapy for atherosclerosis? Circulation, 95: 311-312.
15. Daniel, R.S., K.S. Devi, K.T. Augusti and N.C. Sudhakaran, 2003. Mechanism of action of antiatherogenic and related effects of Ficus bengalensis Linn. Flavonoids in experimental animals. Indian J. Exp. Biol., 41: 296-303.
16. Earle, K.A., D. Harry and K. Zitouni, 2008. Circulating cholesterol as a modulator of risk for renal injury in patients with type 2 diabetes. Diabetes Res. Clin. Pract., 79: 68-73.
17. Elin, R.J. and J.M. Hosseini, 1993. Is the magnesium content of nuts a factor for coronary heart disease? Arch. Int. Med., 153: 779-780.
18. Eliza, P., S. Daisy and V. Ignacimuthu, 2009. Normo¬glycemic and hypolipidemic effect of costunolide isolated from Costus speciosus (Koen ex. Retz.) streptozotocin-induced diabetic rats. Chem. Biol. Interact, 179: 329-334.
19. Farombi, E.O. and O.O. Ige, 2007. Hypolipedemic and antioxidant effects of ethanolic extract from dried calyx of Hibiscus sabdariffa in alloxan-induced diabetic rats. Fundam Clin. Pharmacol., 21: 601-609.
20. Feldman, E.B., 2002. The scientific evidence for a beneficial health relationship between walnuts and coronary heart disease. J. Nutr., 132: 1062S-1101S.
21. Florkowski, C.M., 2002. Management of co-existing diabetes mellitus and dyslipidaemia: Defining the role of thiazolidinediones. Am. J. Cardio vasc Drugs, 2: 15-21.
22. Franz, M.J., J.P. Bantle, C.A. Beebe, J.D. Brunzell, J.L. Chiasson, A. Garg, L.A. Holzmeister, B. Hoogwerf, E. Mayer-Davis, A.D. Mooradian, J.Q. Purnell and Wheeler, 2002. Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications. Diabetes Care, 25: 148-98.
23. Garg, A., A. Bonnie, S.M. Grundy, Z.J. Zhang and R.H. Unger, 1988. Comparison of a high-carbohydrate diet with a high-monounsaturated-fat diet in patients with non-insulin-dependent diabetes mellitus. N. Engl. J. Med., 319: 829-834.
24. Granner, D.K., 1996. Hormones of the pancreas and gastrointestinal tract. In: Murray, R.K., R.K. Granner, P.A. Mayes and V.W. Rodwell (Eds.), Harper's Biochemistry, 24th Edn., Appleton and Lange, Connecticut, USA, pp: 586-587.
25. Griel, A.E. and P.M. Kris-Etherton, 2006. Tree nuts and the lipid profile: A review of clinical studies. Br. J. Nutr., 96: S68-S78.
26. Hamden, K., S. Carreau, S. Lajmi, D. Aloulou, D. kchaou and A. Elfeki, 2008. Protective effect of 17-estradiol on hyperglycemia, stress oxidant, liver dysfunction and histological changes induced by alloxan in male rat pancreas and liver, Steroids, 94: 495-501.
27. Hemalatha, S., A.K. Wahi, P.N. Singh and J.P. Chansouria, 2004. Hypoglycemic activity of Withania coagulans Dunal in streptozotocin-induced diabetic rats. J. Ethnopharmacol., 93: 261-264.
28. Jarald, E.E., S.B. Joshi and D.C. Jain, 2008. Antidiabetic activity of aqueous extract and non polysaccharide fraction of Cynodon dactylon Pers. Indian J. Exp. Biol., 46: 660-667.
29. Jenkins, D.J., J.M. Wong, C.W. Kendall, A. Esfahani, V.W. Ng, T.C. Leong, D.A. Faulkner, E. Vidgen, K.A. Greaves and G. Paul, 2009. The effect of a plant- based low carbohydrate (Eco-Atkins) diet on body weight and blood lipid concentrations in hyperlipidemic subjects. Arch. Int. Med., 169: 1046-1054.
30. Jiang, G.Y., 1996. Practical Diabetes. 1st Edn., Beijing: People's Health Publishing House, pp: 295-296.
31. Kaneto, H., G. Xu, K.H. Song, K. Suxuma, S. Bonner- Weir, A. Sharma and G.C. Weir, 2001. Activation of the hexosamine pathway leads to deterioration of pancreatic a-cell function through the induction of oxidative stress. J. Biol. Chem., 276: 31099-31104.
32. Khaki, A., M. Nouri, F. Fathiazad, H.R. Ahmadi-Ashtiani, H. Rastgar and S. Rezazadeh, 2009. Protective effect of quercetin on spermatogenesis in streptozotocin-induced diabetic rat. J. Med. Plan., 8: 57-64.
33. Kishore, A., G.K. Nampurath, S.P. Mathew, R.T. Zachariah, B.K. Potu, M.S. Rao, M. Valiathan and M.R. Chamallamudi, 2009. Antidiabetic effect through islet cell protection in streptozotocin diabetes: A preliminary assessment of two thiazolidin-4-ones in Swiss albino mice, Chem. Biol. Interact, 177: 242-246.
34. Klevay, L.M., 1993. Copper in nuts may lower heart disease risk. Arch. Intern. Med., 153: 401-402.
35. Laxmi, V., K. Anirudh, K. Basant, K. Umesh and S. Rajesh, 2010. Antidiabetic activity of Cassia occidentalis (Linn) in normal and alloxan-induced diabetic rats. Indian J. Pharmacol., 42: 224-228.
36. Lyra, R., M. Oliveira, D. Lins and N. Cavalcanti, 2006. Prevention of type 2 diabetes mellitus. Arq. Bras. Endocrinol. Metabo., 50: 239-249.
37. Mallick, C., S. Mandal, B. Barik, A. Bhattacharya and D. Ghosh, 2007. Protection of testicular dysfunctions by MTEC, a formulated herbal drug, in streptozotocin induced diabetic rat. Biol. Pharm. Bull., 30: 84-90.
38. Marles, F.J. and N.R. Farnsworth, 1996. Antidiabetic plants and their active constituents: An update Protocol. J. Nat. Med., 85-111.
39. Medina, J. and R. Moreno-Otero, 2005. Pathophysiological basis for antioxidant therapy in chronic liver disease. Drugs, 65: 2445-2461.
40. Mendoza, J.A., A. Drewnowski, A. Cheadle and D.A. Christakis, 2006. Dietary energy density is associated with selected predictors of obesity in U.S. children. J. Nut., 136: 1318-1322.
41. Oksanen, A., 1975. Testicular lesions of streptozotocin diabetic rats. Horm Res., 6: 138-144.
42. Orth, J.M., F.T. Murray and C.W. Bardin, 1979. Ultrastructural changes in Leydig cells of streptozotocin-induced diabetic rats. Anat Rec., 195: 415-430.
43. Posario, P.W., 2010. Normal values of serum IGF-I in adults: Results from a Brazilian population. Arq. Bras. Endocrinol. Metabol., 45: 477-481.
44. Reeves, P.G., F.H. Nielson and G.C. Fahmy, 1993. Reports of the AmericanInstitute of Nutrition, adhoc- wiling committee on reformulation of the AIN Rodent diet. J. Nutr., 123: 1939-1951.
45. Rimm, E.B. and M.J. Stampfer, 1997. The role of antioxidants in preventive cardiology. Curr. Opin Cardiol., 12: 188-194.
46. Sabate, J., 2003. Nut consumption and body weight. Am. J. Clin. Nutr., 78: 647S-650S.
47. Sabate, J., K. Oda and E. Ros, 2010. Nut consumption and blood lipid levels: A pooled analysis of 25 intervention trials. Arch. Int. Med., 170: 821-827.
48. Salmeron, J., F.B. Hu and J.E. Manson, 2001. Dietary fat intake and risk of type 2 diabetes in women. Am. J. Clin. Nutr., 73: 1019-1026.
49. Shah, S.V., R. Baliga, M. Rajapurkar and V.A. Fonseca, 2007. Oxidants in chronic kidney disease. J. Am. Soc. Nephrol., 18: 16-28.
50. Sharma, S., A. Nasir, K. Parbhu, B. Mursy and G. Dev, 2003. Hypoglycemic and hypolipidemic effect of etanolic extract of seeds in alloxan induced diabetic rabbits. J. Ethnopharmacol., 85: 201.
51. Sheridan, M.J., J.N. Cooper, M. Erario and C.E. Cheifetz, 2007. Pistachio nut consumption and serum lipid levels. J. Am. College Nutr., 26: 141-148.
52. Shou-Chieh, W., L. Shiow-Fen, W. Chau-Jong, L. Chao- Hsin, L. Wen-Chin and L. Huei-Jane, 2009. Aqueous extract from hibiscus sabdariffa linnaeus ameliorate diabetic nephropathy via regulating oxidative status and Akt/Bad/14-3-3g in an Exp. Anim. Model eCAM, 4: 1-9.
53. Singh, D.K., P. Winocour and K. Farrington, 2008. Mechanisms of disease: The hypoxic tubular hypothesis of diabetic nephropathy. Nat. Clin. Pract Nephrol., 4: 216-226.
54. Steinberg, D. and A. Lewis, 1997. Oxidative modification of LDL and atherogenesis. Circulation, 95: 1062-1071.
55. Sudha, S., G. Valli, J.P. Mary, J. Arunakaran, P. Govindarajulu and K. Balasu-Bramanian, 1999. Influence of streptozotocin-induced diabetes and insulin treatment on the pituitary-testicular axis during sexual maturation in rat. Endocrinol. Diabetes, 107: 14-20.
56. Tey, S.L., R.C. Brown, A.W. Chisholm, C.M. Delahunty, A.R. Gray and S.M. Williams, 2011. Effects of different forms of hazelnuts on blood lipids and • - tocopherol concentrations in mildly hypercholesterolemic individuals. Eur. J. Clin. Nutr., 65: 117-124.
57. Trevisan, M., CV. Krogh, J. Freudenheim, A. Blake, P. Muti, S. Panico, E. Farinaro, M. Mancini, A. Menotti and G. Ricci, 1990. Consumption of olive oil butter and vegetable oils and coronary heart disease risk factors: The Research Group ATS-RF2 of the Italian National Research Council. JAMA., 263: 688-692.
58. Uladimir, O.M., 2003. Coronary risk factor. J. Diabet. Assoc. India, 29: 3-8.
59. Weststrate, J.A. and G.W. Meijer, 1998. Plant sterol- enriched margarines and reduction of plasma total- and LDL-cholesterol concentrations in normo- cholesterolaemic and mildly hypercholesterolaemic subjects. Eur. J. Clin. Nutr., 52: 334-343.
60. Willett, W.C., 1998. Is dietary fat a major determinant of body fat? Am. J. Clin. Nutr., 67: 556-562.
61. Young, D.S., 2001. Effects of disease on clinical Lab. tests, 4th Edn., AACC.